Fit For ATMPs? Creating an EU Regulatory Framework that Works for Transformative Therapies
Hosted by the MEP Interest Group for Transformative Therapies (TRANSFORM)Register
This meeting will bring together policy-makers (MEPs, representatives of EU institutions, national representatives), regulators (EMA), patient representatives, medical experts, scientists, researchers, industry representatives and academics to discuss recommended changes in policy and practice, and offer solutions to ensure a regulatory framework that is fit-for purpose for ATMPs and has patient safety at its centre.
The discussion will focus on legislative dossiers that touch on the ATMP regulatory framework, namely the review of the Blood, Tissues and Cells legislation (expected mid-July) and the General Pharmaceutical legislation.
A recording will be made available after the event.